<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font18">HIV- </span>
   <span class="font15">with </span>
   <span class="font15">were </span>
   <span class="font14">resistance </span>
   <span class="font14">for </span>
   <span class="font13">sequences </span>
   <span class="font13">was </span>
   <span class="font13">(.â€".) </span>
   <span class="font13">{background </span>
   <span class="font12">(.) </span>
   <span class="font12">The </span>
   <span class="font12">antiretroviral </span>
   <span class="font12">subtype </span>
   <span class="font12">BR_MA </span>
   <span class="font12">recombinants </span>
   <span class="font12">margin </span>
   <span class="font12">{border-style </span>
   <span class="font12">from </span>
   <span class="font11">[]. </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Brazil. </span>
   <span class="font11">Male </span>
   <span class="font11">al., </span>
   <span class="font11">have </span>
   <span class="font11">Brazil </span>
   <span class="font11">Sciences </span>
   <span class="font11">clusters </span>
   <span class="font11">Biology </span>
   <span class="font11">analysis </span>
   <span class="font11">been </span>
   <span class="font11">patients </span>
   <span class="font11">â€". </span>
   <span class="font11">Antiretroviral </span>
   <span class="font11">among </span>
   <span class="font11">genetic </span>
   <span class="font11">has </span>
   <span class="font11">query </span>
   <span class="font11">subtypes </span>
   <span class="font11">Health </span>
   <span class="font11">Pathogens </span>
   <span class="font11">Viral </span>
   <span class="font11">diversity </span>
   <span class="font11">frequency </span>
   <span class="font11">higher </span>
   <span class="font11">individuals </span>
   <span class="font11">recombinant </span>
   <span class="font11">study </span>
   <span class="font11">using </span>
   <span class="font11">which </span>
   <span class="font11">AIDS </span>
   <span class="font11">HIV </span>
   <span class="font11">identified </span>
   <span class="font11">%CI: </span>
   <span class="font11">Brazilian </span>
   <span class="font11">Life </span>
   <span class="font11">Northeast </span>
   <span class="font11">University </span>
   <span class="font11">are </span>
   <span class="font11">high </span>
   <span class="font11">phylogenetic </span>
   <span class="font11">state </span>
   <span class="font11">than </span>
   <span class="font11">that </span>
   <span class="font11">this </span>
   <span class="font10">(): </span>
   <span class="font10">Brazil[], </span>
   <span class="font10">Federal </span>
   <span class="font10">MaranhÃ£o, </span>
   <span class="font10">Phylogenetic </span>
   <span class="font10">data </span>
   <span class="font10">â€" </span>
   <span class="font10">.â€".) </span>
   <span class="font10">Analysis </span>
   <span class="font10">Fig </span>
   <span class="font10">HIV: </span>
   <span class="font10">Medicine </span>
   <span class="font10">Resistance </span>
   <span class="font10">Transmitted </span>
   <span class="font10">Viruses </span>
   <span class="font10">analyzed </span>
   <span class="font10">cases </span>
   <span class="font10">cluster </span>
   <span class="font10">mutations </span>
   <span class="font10">obtained </span>
   <span class="font10">one </span>
   <span class="font10">px; </span>
   <span class="font10">recombination </span>
   <span class="font10">therapy </span>
   <span class="font10">{font-family </span>
   <span class="font10">(%) </span>
   <span class="font10">(%CI: </span>
   <span class="font10">(.%) </span>
   <span class="font10">Drug </span>
   <span class="font10">Ministry </span>
   <span class="font10">NRTIs </span>
   <span class="font10">PIs </span>
   <span class="font10">PLoS </span>
   <span class="font10">font-size </span>
   <span class="font10">large </span>
   <span class="font10">lower </span>
   <span class="font10">rate </span>
   <span class="font10">sequence </span>
   <span class="font10">showed </span>
   <span class="font10">strains </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(CI%) </span>
   <span class="font10">Among </span>
   <span class="font10">CRFs </span>
   <span class="font10">Department </span>
   <span class="font10">However, </span>
   <span class="font10">Immunodeficiency </span>
   <span class="font10">MA, </span>
   <span class="font10">MaranhÃ£o </span>
   <span class="font10">Methods </span>
   <span class="font10">Microbiology </span>
   <span class="font10">This </span>
   <span class="font10">double; </span>
   <span class="font10">failure </span>
   <span class="font10">had </span>
   <span class="font10">its </span>
   <span class="font10">number </span>
   <span class="font10">performed </span>
   <span class="font10">period </span>
   <span class="font10">pol </span>
   <span class="font10">proportion </span>
   <span class="font10">protease </span>
   <span class="font10">transmission </span>
   <span class="font10">version </span>
   <span class="font10">virological </span>
   <span class="font10">(.%, </span>
   <span class="font10">.%; </span>
   <span class="font10">Brazil, </span>
   <span class="font10">CRF_BF </span>
   <span class="font10">Control </span>
   <span class="font10">Database </span>
   <span class="font10">Evolutionary </span>
   <span class="font10">Female </span>
   <span class="font10">High </span>
   <span class="font10">Hum </span>
   <span class="font10">Microbial </span>
   <span class="font10">NNRTIs </span>
   <span class="font10">One. </span>
   <span class="font10">Pernambuco, </span>
   <span class="font10">Res </span>
   <span class="font10">Research </span>
   <span class="font10">Thus, </span>
   <span class="font10">[], </span>
   <span class="font10">alignment </span>
   <span class="font10">all </span>
   <span class="font10">also </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">composed </span>
   <span class="font10">epidemic </span>
   <span class="font10">may </span>
   <span class="font10">men </span>
   <span class="font10">molecular </span>
   <span class="font10">only </span>
   <span class="font10">original </span>
   <span class="font10">other </span>
   <span class="font10">our </span>
   <span class="font10">reference </span>
   <span class="font10">related </span>
   <span class="font10">secondary </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">tree </span>
   <span class="font10">two </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">():â€". </span>
   <span class="font10">(aLTR </span>
   <span class="font10">.â€".), </span>
   <span class="font10">Characterization </span>
   <span class="font10">Diversity </span>
   <span class="font10">Evol. </span>
   <span class="font10">Genetic </span>
   <span class="font10">HIV/AIDS </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">Imperatriz, </span>
   <span class="font10">Infections, </span>
   <span class="font10">Lentivirus </span>
   <span class="font10">NNRTIs, </span>
   <span class="font10">North </span>
   <span class="font10">Organisms </span>
   <span class="font10">Prevention </span>
   <span class="font10">ReisM.N.G., </span>
   <span class="font10">Retroviruses </span>
   <span class="font10">Retroviruses. </span>
   <span class="font10">Sequence </span>
   <span class="font10">Sexually </span>
   <span class="font10">Surveillance, </span>
   <span class="font10">Tenofovir </span>
   <span class="font10">Transmission </span>
   <span class="font10">antirretroviral </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">breakpoints </span>
   <span class="font10">color). </span>
   <span class="font10">compared </span>
   <span class="font10">country </span>
   <span class="font10">courier; </span>
   <span class="font10">detected </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">evolutionary </span>
   <span class="font10">infected </span>
   <span class="font10">infection </span>
   <span class="font10">information </span>
   <span class="font10">level </span>
   <span class="font10">major </span>
   <span class="font10">male </span>
   <span class="font10">more </span>
   <span class="font10">non-B </span>
   <span class="font10">not </span>
   <span class="font10">nucleotide </span>
   <span class="font10">observed </span>
   <span class="font10">part </span>
   <span class="font10">population </span>
   <span class="font10">pt;} </span>
   <span class="font10">region, </span>
   <span class="font10">regions </span>
   <span class="font10">sequencing </span>
   <span class="font10">significantly </span>
   <span class="font10">software </span>
   <span class="font10">statistical </span>
   <span class="font10">there </span>
   <span class="font10">these </span>
   <span class="font10">transmissions </span>
   <span class="font10">used </span>
   <span class="font10">while </span>
  </p>
 </body>
</html>
